1
|
Ito K, Kita M, Hosokawa K, Toyoda S, Kozuki M, Hayashi M, Takata T, Miyoshi Y, Koshiba H, Tabata T. Phase I-II trial of irinotecan (CPT) and cisplatin (P) as concurrent chemo-radiotherapy (CCRT) for patients (pts) with primary local advanced cervical cancer (LACC): A KCOG 0328 trial. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.15002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
15002 Background: Though CCRT based on P is now recommended in LACC, there is no standard regimen. We conducted a phase I-II trial of CPT and P as CCRT in pts with primary LACC. Methods: Eligibility criteria: histologically confirmed primary LACC as FIGO stage III to IVb by para-aortic lymphnode (PAN) metastasis, age 16–75 years, ECOG performance status <2, adequate bone marrow, hepatic and renal function, and written informed consent. Radiotherapy (RT) consisted of external beam 5040cGy in 28 fractions followed by single application brachytherapy, delivering 1800–2400 cGy to point A in 3–4 fractions. The doses of chemotherapy (CT) were set up as follows: dose level (DL) 0; CPT 20 mg/m2, P 30 mg/m2, DL1; CPT 25mg/m2, P 30 mg/m2, DL2; CPT 30 mg/m2, P 30 mg/m2, and the starting level was chosen DL1. CT was curried out weekly 5 cycles concurrently with RT. Toxicities were assessed according to NCI-CTC ver2.0J and responses were assessed according to RECIST. Results: So far 9 pts have been entered. The median age was 52 years (range 29 -73). All pts were FIGO stage IIIb and histrogically squamous cell carcinoma. Among the first 2 pts in DL1, 2 dose-limiting toxicities (DLT) were observed (delay of treatment due to grade 3 diarrhea and nausea) resulting in dose reduction to DL0. In the next 3 pts in DL0, no DLTs were observed and the study is ongoing as phase II. All pts were evaluable for response and toxicity. Eight complete (CR) and 1 partial response (PR) were seen at target region of cervix. But 2 pts showed progressive disease (PD) at non-target region of PAN, lung and liver, then overall response rate assessed by RECIST was 77.8% (CR 7, PD 2). Now the median follow up period is 16 months (range 6 -30). So far 2 pts of PD died and 3 pts relapsed. The median survival time is 10+ months (range 6+ -30+). Toxicity in DL0 was observed febrile neutropenia in 1 pt only. Conclusions: The CCRT with CPT and P in DL0 is feasible and shows promising activity in pts with primary LACC. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- K. Ito
- Kansai Rosai Hospital, Amagasaki, Hyogo, Japan; Kobe City General Hospital, Kobe, Japan; Kyoto Prefectural University School of Medicine, Kyoto, Japan; Nara Prefectural Nara Hospital, Nara, Japan; Mie University School of Medicine, Mie, Japan
| | - M. Kita
- Kansai Rosai Hospital, Amagasaki, Hyogo, Japan; Kobe City General Hospital, Kobe, Japan; Kyoto Prefectural University School of Medicine, Kyoto, Japan; Nara Prefectural Nara Hospital, Nara, Japan; Mie University School of Medicine, Mie, Japan
| | - K. Hosokawa
- Kansai Rosai Hospital, Amagasaki, Hyogo, Japan; Kobe City General Hospital, Kobe, Japan; Kyoto Prefectural University School of Medicine, Kyoto, Japan; Nara Prefectural Nara Hospital, Nara, Japan; Mie University School of Medicine, Mie, Japan
| | - S. Toyoda
- Kansai Rosai Hospital, Amagasaki, Hyogo, Japan; Kobe City General Hospital, Kobe, Japan; Kyoto Prefectural University School of Medicine, Kyoto, Japan; Nara Prefectural Nara Hospital, Nara, Japan; Mie University School of Medicine, Mie, Japan
| | - M. Kozuki
- Kansai Rosai Hospital, Amagasaki, Hyogo, Japan; Kobe City General Hospital, Kobe, Japan; Kyoto Prefectural University School of Medicine, Kyoto, Japan; Nara Prefectural Nara Hospital, Nara, Japan; Mie University School of Medicine, Mie, Japan
| | - M. Hayashi
- Kansai Rosai Hospital, Amagasaki, Hyogo, Japan; Kobe City General Hospital, Kobe, Japan; Kyoto Prefectural University School of Medicine, Kyoto, Japan; Nara Prefectural Nara Hospital, Nara, Japan; Mie University School of Medicine, Mie, Japan
| | - T. Takata
- Kansai Rosai Hospital, Amagasaki, Hyogo, Japan; Kobe City General Hospital, Kobe, Japan; Kyoto Prefectural University School of Medicine, Kyoto, Japan; Nara Prefectural Nara Hospital, Nara, Japan; Mie University School of Medicine, Mie, Japan
| | - Y. Miyoshi
- Kansai Rosai Hospital, Amagasaki, Hyogo, Japan; Kobe City General Hospital, Kobe, Japan; Kyoto Prefectural University School of Medicine, Kyoto, Japan; Nara Prefectural Nara Hospital, Nara, Japan; Mie University School of Medicine, Mie, Japan
| | - H. Koshiba
- Kansai Rosai Hospital, Amagasaki, Hyogo, Japan; Kobe City General Hospital, Kobe, Japan; Kyoto Prefectural University School of Medicine, Kyoto, Japan; Nara Prefectural Nara Hospital, Nara, Japan; Mie University School of Medicine, Mie, Japan
| | - T. Tabata
- Kansai Rosai Hospital, Amagasaki, Hyogo, Japan; Kobe City General Hospital, Kobe, Japan; Kyoto Prefectural University School of Medicine, Kyoto, Japan; Nara Prefectural Nara Hospital, Nara, Japan; Mie University School of Medicine, Mie, Japan
| |
Collapse
|
2
|
Ogata S, Ito K, Kadoike K, Egawa T, Kinugasa Y, Kozuki M. The incidence of bone pain with granulocyte colony stimulating factor (G-CSF) administration and the effect of hydroxyzine. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.8242] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- S. Ogata
- Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
| | - K. Ito
- Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
| | - K. Kadoike
- Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
| | - T. Egawa
- Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
| | | | - M. Kozuki
- Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
| |
Collapse
|
3
|
Mu J, Kanzaki T, Tomimatsu T, Fukuda H, Wasada K, Fujii E, Endoh M, Kozuki M, Murata Y, Sugimoto Y, Ichikawa A. Expression of apoptosis in placentae from mice lacking the prostaglandin F receptor. Placenta 2002; 23:215-23. [PMID: 11945089 DOI: 10.1053/plac.2001.0759] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
This study aimed to investigate the changes in apoptosis in the placenta and decidua of pregnant mice lacking the prostaglandin F receptor. Mouse placentae were removed from fetuses on days 10-23 of pregnancy. Apoptotic cells were examined by a DNA fragmentation assay and the terminal deoxynucleotidyl transferase-mediated dUDP nick end-labelling (TUNEL) technique. The placenta and decidual weight increased before day 18 and 14 of pregnancy, and then decreased with gestational day. After day 19, the fetuses gradually died in the uterus. All fetuses died in the uterus on day 23 of pregnancy. The number of apoptosis was not significantly different between wild type and FP-deficient mice before day 18 of pregnancy by DNA fragmentation and TUNEL staining. The DNA fragmentation was always more pronounced in decidual tissue on each day of pregnancy. DNA laddering on placentae was more extensive on day 22 than day 18. In placenta, most TUNEL-positive cells were detected in trophoblast and stromal cells. A higher intensity of apoptotic cells was in the decidual basalis. The main area was the centre of the decidual basalis, and was in decrease toward to margin of placenta. The index of TUNEL positive cells increased as gestation progressed toward termination. Especially, it was prominent in the placentae on day 22 compared with that day 18 of pregnancy. The increased TUNEL-positive staining in syncytiotrophoblast surface was found in placenta at post-term, compared with those at term. Apoptosis may provide insights into both normal placental development and placental dysfunction during an abnormal pregnancy from post-term pregnancy.
Collapse
Affiliation(s)
- J Mu
- Department of Obstetrics and Gynecology, Faculty of Medicine, Osaka University, 2-2 Yamadaoka Suita, Osaka, 565-0871 Japan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Okazaki T, Ozaki S, Nagaoka T, Kozuki M, Sumita S, Tanaka M, Osakada F, Kishimura M, Kakutani T, Nakao K. Antigen-specific T(h)1 cells as direct effectors of Propionibacterium acnes-primed lipopolysaccharide-induced hepatic injury. Int Immunol 2001; 13:607-13. [PMID: 11312248 DOI: 10.1093/intimm/13.5.607] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
T(h)1 cells are cytotoxic effector cells that utilize Fas ligand (FasL) and tumor necrosis factor. The physiological roles of cytotoxic T(h)1 cells are considered to be immunoregulation by eliminating autoreactive lymphocytes or hyper-activated foreign antigen-specific lymphocytes. Their pathological roles, however, remain to be clarified. To investigate whether T(h)1 cells can destroy organs, we generated a Propionibacterium acnes-specific T(h)1 clone from C57BL/6 mice and tested whether the clone could serve as an effector in a P. acnes-primed lipopolysaccharide (LPS)-induced hepatic injury system, one of the septic shock models. B6SMN:C3H-FasL(gld) (B6-gld) mice, which were deficient in functional FasL, were resistant to P. acnes/LPS-induced hepatic shock. The T(h)1 clone rendered B6-gld mice sensitive to the hepatic shock after the i.v. transfer. The hepatic injury in the clone-transferred B6-gld mice, which was evaluated by both biochemical and histological examination, was inhibited by an anti-FasL mAb that we developed. These results suggested that bacterial antigen-specific T(h)1 cells like this clone can participate in organ destruction in vivo as one of the cytotoxic effectors and play a critical role in endotoxin-induced hepatic injury.
Collapse
Affiliation(s)
- T Okazaki
- Takasago Research Laboratories, Kaneka Corp., Takasago, Hyogo 676-8688, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Ma W, Ozaki S, Sobajima J, Uesugi H, Murakami M, Tanaka M, Kozuki M, Hashimoto H, Fujita Y, Kawabata D, Osakada F, Shirakawa H, Yoshida M, Hayami M, Nakao K. Detection of anti-neutrophil cytoplasmic antibodies in MRL/Mp-lpr/lpr mice and analysis of their target antigens. Autoimmunity 2000; 32:281-91. [PMID: 11191287 DOI: 10.3109/08916930008994102] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Anti-neutrophil cytoplasmic antibodies (ANCA) have been widely studied and recognized to be clinically very important for some human diseases including systemic rheumatic diseases. We analyzed ANCA response and their target antigens in MRL/Mp-lpr/lpr (MRL-lpr) mice, an animal model of systemic rheumatic disease. P-ANCA was detected in 57% of the mice. Antibodies to the known P-ANCA target antigens at the same age were examined. Among these, antibodies to high mobility group (HMG) proteins HMG1 and HMG2 were detected in 57% of the mice, 75% of which were also positive for P-ANCA. These anti-HMG1/HMG2 activities were absorbed by preincubation with a mixture of HMG1 and HMG2. In contrast, antibodies to myeloperoxidase and cathepsin G were detected in 14% and 7%, respectively, but these activities were not inhibited by preincubation with corresponding antigens. In addition, the titers of P-ANCA and anti-HMG1/HMG2 antibodies in MRL-lpr mice were significantly correlated with each other. Thus, HMG1 and HMG2 were considered to be significant target antigens of P-ANCA in MRL-lpr mice.
Collapse
Affiliation(s)
- W Ma
- Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|